These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1682739)

  • 1. Erythropoietin and spontaneous platelet aggregation in haemodialysis patients.
    Taylor JE; Henderson IS; Stewart WK; Belch JJ
    Lancet; 1991 Nov; 338(8779):1361-2. PubMed ID: 1682739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anemia in chronic renal failure. The role of L-carnitine in the treatment of anemia of hemodialyzed patients].
    Wanic-Kossowska M; Kurzawska-Firlej D; Kaźmierski M; Czekalski S
    Pol Arch Med Wewn; 2003 Jan; 109(1):105-11. PubMed ID: 12879773
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis.
    Fabris F; Cordiano I; Randi ML; Casonato A; Montini G; Zacchello G; Girolami A
    Pediatr Nephrol; 1991 Mar; 5(2):225-8. PubMed ID: 2031840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin and uremic platelet aggregation in vivo and in vitro.
    Malyszko JS; Malyszko J; Pawlak K; Mysliwiec M
    Int J Clin Lab Res; 1996; 26(3):199-202. PubMed ID: 8905452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of recombinant human erythropoietin on thrombocyte aggregation capacity and on the blood prostanoid level in patients with chronic kidney failure on hemodialysis].
    Rud'ko IA; Pokrovskiĭ IuA; Ermolenko VM; Kubatiev AA
    Ter Arkh; 1991; 63(10):128-30. PubMed ID: 1805410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of erythropoietin therapy and withdrawal on blood coagulation and fibrinolysis in hemodialysis patients.
    Taylor JE; Belch JJ; McLaren M; Henderson IS; Stewart WK
    Kidney Int; 1993 Jul; 44(1):182-90. PubMed ID: 8355460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of r-HuEPO on platelet function and coagulation factors in hemodialysis patients].
    Kinugasa E; Nabeshima K; Niikura K; Kawabe S; Akizawa T; Kitaoka T; Koshikawa S
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1109-16. PubMed ID: 2287103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extrinsic coagulation pathway in peritoneally dialyzed patients treated with erythropoietin].
    Małyszko J; Małyszko JS; Suchowierska E; Pawlak K; Myśliwiec M
    Przegl Lek; 2002; 59(3):139-41. PubMed ID: 12184025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin.
    Heptinstall S; Fox S; Crawford J; Hawkins M
    Thromb Res; 1986 Apr; 42(2):215-23. PubMed ID: 3715801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
    Violi F; Praticò D; Iuliano L; Balsano F
    J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation in erythropoietin treated dialysis patients.
    Taylor JE; Henderson IS; Stewart WK; Belch JJ
    Platelets; 1992; 3(1):47-52. PubMed ID: 21043900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin increases platelet aggregation in chronic hemodialysis patients.
    Sayinalp N; Erdem Y; Ilhami Ozcebe O; Büyükaşik Y; Cağlar S; Dündar SV
    Thromb Res; 1998 May; 90(4):195-8. PubMed ID: 9692619
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoietin does not increase whole-blood platelet aggregation in vitro.
    Taylor JE; Belch JJ; Henderson IS; Stewart WK
    Nephrol Dial Transplant; 1994; 9(5):556-8. PubMed ID: 8090338
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.
    Saniabadi AR; Fisher TC; McLaren M; Belch JF; Forbes CD
    Cardiovasc Res; 1991 Mar; 25(3):177-83. PubMed ID: 2029709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of "spontaneous" platelet aggregation in whole blood.
    Harrison MJ; Pollock SS; Steiner M; Weisblatt E
    Atherosclerosis; 1985 Dec; 58(1-3):199-203. PubMed ID: 4091879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of haemostasis in fifteen uraemic patients subjected to chronic haemodialysis (author's transl)].
    Barrantes Boulanger A; Soto Quirós M; Salas González R
    Sangre (Barc); 1980; 25(3):289-99. PubMed ID: 7414445
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-dose aspirin does not prevent thrombovascular accidents in low-risk haemodialysis patients during treatment with recombinant human erythropoietin.
    Kooistra MP; van Es A; Marx JJ; Hertsig ML; Struyvenberg A
    Nephrol Dial Transplant; 1994; 9(8):1115-20. PubMed ID: 7800210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propyl gallate-induced platelet aggregation in patients with end-stage renal disease: the influence of the haemodialysis procedure.
    Eleftheriadis T; Antoniadi G; Liakopoulos V; Tsiandoulas A; Barboutis K; Stefanidis I
    Nephrology (Carlton); 2006 Feb; 11(1):3-8. PubMed ID: 16509924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between products of fibrin degradation and platelet dysfunction in chronic renal failure. Effects of aspirin].
    Lazzari MA; Pavlovsky M; Martínez Canaveri A
    Medicina (B Aires); 1977; 37(2):97-105. PubMed ID: 895494
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of erythropoietin on platelet function in uraemic children on haemodialysis.
    Turi S; Soos J; Torday C; Bereczki C; Havass Z
    Pediatr Nephrol; 1994 Dec; 8(6):727-32. PubMed ID: 7696114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.